Nov 02, 2020 9:00am EST CohBar to Announce 2020 Third Quarter Financial Results and Provide Business Update on November 16, 2020
Oct 29, 2020 9:00am EDT CohBar to Host Key Opinion Leader Meeting on Antifibrotic Peptides for the Potential Treatment of Idiopathic Pulmonary Fibrosis
Oct 27, 2020 9:00am EDT CohBar to Participate at ROTH Capital COVID-19 Therapeutics in Development Event
Oct 26, 2020 9:00am EDT CohBar Antifibrotic Peptide in Combination with Nintedanib Shows Enhanced Effects in an Idiopathic Pulmonary Fibrosis Model
Oct 08, 2020 9:00am EDT CohBar’s CEO to Participate on the Emerging Companies Panel at the Targeting Metabesity Conference
Sep 10, 2020 4:05pm EDT CohBar to Present at the Oppenheimer Fall Healthcare, Life Sciences, & MedTech Summit